Medicare Coverage for GLP-1 Medications: What You Need to Know

What Medicare Does and Does Not Cover for GLP-1s

Medicare Part D (stand-alone drug plans) and Medicare Advantage plans with drug coverage generally may cover GLP-1 medications when they are prescribed for FDA-approved indications that Part D allows. Examples include semaglutide for type 2 diabetes (Ozempic), liraglutide for diabetes (Victoza), dulaglutide (Trulicity), and tirzepatide for diabetes (Mounjaro). Coverage still depends on each plan’s formulary, cost tier, and rules like prior authorization or step therapy.

By law, Part D excludes drugs “for anorexia, weight loss, or weight gain.” However, in 2024 the FDA approved Wegovy (semaglutide) to reduce cardiovascular risk in certain adults with obesity or overweight and established cardiovascular disease. Many experts note that Part D plans may cover Wegovy for this specific heart-risk indication (not for weight loss), subject to plan rules. In 2024, the FDA also approved Zepbound (tirzepatide) to treat obstructive sleep apnea (OSA) in adults with obesity; some Part D plans may consider coverage for that non-weight-loss indication as well. Always check your plan’s formulary and criteria.

How to Get Coverage Through Your Medicare Plan

Step 1: Check your plan’s formulary

Use the Medicare Plan Finder or your plan’s website to look up the exact drug and dose (for example, “semaglutide 1 mg/dose pen” or “tirzepatide 5 mg”). Confirm the tier, any preferred-pharmacy pricing, and whether prior authorization, step therapy, or quantity limits apply.

Step 2: Confirm you meet the plan’s medical criteria

Most plans publish clinical criteria for GLP-1 coverage. For diabetes indications, criteria often include a diagnosis of type 2 diabetes, a recent A1C, and documentation that you have tried or cannot tolerate first-line therapies (like metformin). For Wegovy’s cardiovascular indication, plans commonly require documentation of established cardiovascular disease plus BMI thresholds consistent with the FDA label. Ask your prescriber to review the plan’s policy before submitting a request.

Step 3: Submit prior authorization (PA) with complete support

Have your prescriber file the plan’s PA form and include chart notes, recent labs (A1C, weight/BMI as applicable), medication history, and reasons other options are unsuitable or insufficient.
Match the request to an FDA-approved indication that Part D allows, and to any plan-specific rules (for example, step therapy or dosing limits).
Track the timeline – most plans respond within a few business days for standard requests and faster for urgent needs.
If denied: request an exception or appeal

You can seek a formulary exception (for a non-covered drug), a tiering exception (to pay less), or appeal a denial. Start with a “coverage determination” request; if denied, follow the appeal levels outlined at
Medicare.gov
. Ask your prescriber to write a strong letter of medical necessity linking your health history to the plan’s criteria and the drug’s FDA-approved use.

Eligibility Basics Plans Often Use

Diagnosis: Type 2 diabetes for Ozempic, Trulicity, Victoza, or Mounjaro; cardiovascular disease plus qualifying BMI for Wegovy’s heart-risk indication; OSA with obesity for Zepbound’s OSA indication (plan-dependent).
Therapy history: Tried/tolerated or had contraindications to first-line agents (for diabetes: metformin, sometimes SGLT2 inhibitors), or documented need based on guidelines and comorbidities.
Clinical thresholds: A1C results, BMI, and presence of conditions like ASCVD, CKD, or heart failure, per the drug’s label and plan policy.
Safety and adherence: No contraindications, willingness to use injection devices, and monitoring (glucose, side effects).

Smart Ways to Save if You Cannot Get Medicare Coverage

Shop plans each year (or consider a Special Enrollment Period)

Plans vary widely. During Open Enrollment, use the Plan Finder to compare total yearly costs for your exact drugs at your preferred pharmacies. If you have a qualifying life event, you may get a Special Enrollment Period to switch sooner.

Apply for Extra Help (Low-Income Subsidy)

Extra Help can dramatically reduce Part D premiums, deductibles, and copays. Even if you were denied before, rules improved recently – apply again if your finances changed. Some states also offer State Pharmaceutical Assistance Programs that coordinate with Part D.

Explore patient assistance programs (PAPs)

Check independent directories like NeedyMeds and the Medicine Assistance Tool.
Review manufacturer options: NovoCare (Novo Nordisk) and Lilly Cares (Eli Lilly). Manufacturer copay cards usually exclude Medicare, but need-based PAPs may help some enrollees.
Ask your clinician’s office to help apply – PAP approvals often hinge on complete documentation and income verification.
Use pharmacy discounts (cash) wisely

Drug discount tools like GoodRx or SingleCare sometimes beat your plan’s copay for non-covered medications. Two cautions: you cannot combine a coupon with a Part D claim, and cash purchases generally do not count toward your Part D out-of-pocket totals. Ask the pharmacy to price both ways before you decide.

Check 340B/community health centers

Some eligible clinics and hospitals purchase drugs at 340B discounts and may pass on savings to their patients. Policies vary – many programmes can only dispense discounted medications to their own patients, and supplies of certain GLP-1s have been tight.

Consider clinical trials

Trials may cover study medications and related care. Search
ClinicalTrials.gov
for your condition and medication class (for example, “GLP-1 diabetes” or “tirzepatide”). Discuss risks and benefits with your clinician.

What Will It Cost If Covered?

Costs depend on your plan’s tiering, pharmacy choice, and coverage rules. High-tier brand drugs can carry significant copays or coinsurance until you hit plan thresholds. In 2025, Part D adds a $2,000 annual out-of-pocket cap and an option to spread costs monthly through the Medicare Prescription Payment Plan. Ask your plan how your GLP-1 would be tiered and what your monthly cost looks like at preferred versus non-preferred pharmacies.

Quick Tips and Common Pitfalls

Match indication to coverage: For Medicare, indication matters. A GLP-1 for diabetes may be covered when a version solely for weight management is not.
Use the exact drug name and dose: Formularies list specific strengths; a covered 0.25/0.5 mg pen does not guarantee the 1 mg pen is covered.
Be specific in PA requests: Include labs, BMI (if relevant), prior drug trials, side effects, and contraindications.
Know the rules you can challenge: Step therapy and non-coverage can sometimes be overridden with a well-supported exception or appeal.
Avoid unsafe sources: Be cautious of compounded or imported semaglutide; these are not FDA-approved and can carry safety risks.
Re-shop every year: Formularies and tiers change – recheck your plan during Open Enrollment.

Putting It Together: A Quick Action Plan

Look up your drug on your plan’s formulary and note tier and rules.
Ask your prescriber to confirm you meet the plan’s criteria and gather supporting records.
Submit prior authorization; if denied, request a coverage determination and consider an exception or appeal.
Price the medication at preferred pharmacies and mail order; check cash prices via discount tools if not covered.
Explore Extra Help, state programmes, PAPs, and 340B options if costs remain high.
With the right diagnosis documentation and a clear prior authorization, many people do obtain Medicare coverage for GLP-1 medications – and if your first attempt does not work, the savings programmes above can still help you access treatment.